Biotronik Will Launch Telemetry Pacemaker Following Marketing Trial
This article was originally published in The Gray Sheet
Executive Summary
Biotronik will conduct a 90-day marketing trial of its BAO3 pacemaker and Home Monitoring System before fully launching the products in the U.S. market.